To further investigate the effects of GLP-1R in ASM cells from COPD patients, overexpression or silencing of GLP-1R in ASM cells was performed
A systematic review published in Diabetes, Obesity and Metabolism examined lean body mass changes across GLP-1 based therapies
At French Peptides, we offer the version without DAC (Mod GRF 1-29, CAS 863288-34-0) to preserve the natural secretion profile
Mounjaro offers three maintenance dose options (5 mg, 10 mg, and 15 mg), giving you and your prescriber more flexibility to find the dose that balances effectiveness with tolerability
European Commission authorisation is still pending and Novo Nordisk plans a launch outside the US in the second half of 2026
Pregnancy: If pregnancy is suspected